Table 1.
Variable | No. of patients |
---|---|
Age at diagnosis | |
≤67 years | 112 |
>67 years | 106 |
Race | |
White | 167 |
Black | 14 |
Hispanic | 17 |
Asian | 18 |
Not recorded | 2 |
Gender | |
Female | 111 |
Male | 107 |
Stage | |
Stage IA | 8 |
Stage IB | 16 |
Stage IIA | 36 |
Stage IIB | 158 |
Pathology T | |
T1 | 13 |
T2 | 42 |
T3 | 163 |
Pathology N | |
N0 | 61 |
N1 | 157 |
Metastatic lymph nodes* | |
≤3 | 80 |
>3 | 75 |
Missing | 2 |
Percentage of metastatic lymph nodes* | |
≤25% | 78 |
>25% | 77 |
Missing | 2 |
Differentiation | |
Poor | 111 |
Moderate | 81 |
Well | 19 |
Missing | 7 |
Localization | |
Proximal pancreas (head/neck) | 184 |
Distal pancreas (body/tail) | 34 |
Tumour size | |
≤2 cm | 41 |
>2 cm | 173 |
Missing | 4 |
Smoking | |
Never | 62 |
Former/Current | 75 |
Missing | 81 |
Alcohol | |
Never | 106 |
Former/Current | 22 |
Missing | 90 |
Chronic Pancreatitis | |
No | 74 |
Yes | 144 |
History of other cancer | |
No | 149 |
Yes | 33 |
Missing | 36 |
Cholelithiasis | |
No | 190 |
Yes | 28 |
Diabetes mellitus | |
No | 124 |
Yes | 60 |
Missing | 34 |
AST | |
Normal | 136 |
Abnormal | 63 |
Missing | 19 |
ALT | |
Normal | 135 |
High | 69 |
Missing | 14 |
Alkaline phosphatase | |
Normal | 174 |
Abnormal | 31 |
Not recorded | 13 |
Albumin | |
Normal | 28 |
Abnormal | 177 |
Missing | 13 |
Total bilirubin | |
Normal | 169 |
Abnormal | 36 |
Missing | 13 |
CA 19-9 | |
<200 U/mL | 112 |
≥200 U/mL | 53 |
Missing | 53 |
CEA | |
Normal | 89 |
High | 77 |
Missing | 52 |
Chemotherapy | |
No adjuvant chemotherapy | 109 |
Adjuvant chemotherapy | 109 |
Surgery | |
Pancreatectomy (distal or total) and splenectomy | 29 |
Whipple procedure | 189 |
Family history** | |
Breast, ovarian cancer | 13 (1) |
Pancreatic cancer | 11 (4) |
Gastrointestinal (Other) | 8 (0) |
Other types | 17 (3) |
Not contributory | 52 |
Missing | 122 |
Split at the median.
At least 1st degree relative (pairs of 1st degree relatives in parenthesis).